Society for Brain Mapping & Therapeutics (SBMT) 16th Annual Congress

Society for Brain Mapping & Therapeutics (SBMT) 16th Annual Congress is organized by Society for Brain Mapping & Therapeutics (SBMT) and will be held from Mar 15 - 17, 2019 at Los Angeles Convention Center, Los Angeles, California, United States of America.

The target audience for this medical event is Neuroscientists, Neurosurgeons, Neurologists, radiologists, pathologists, Oncologists, Chemists, engineers (material, electrical, biomedical, aeronautics and computer), stem cell and molecular biologists, nanotechnologists, pharmacologists and rehabilitation medicine scientists and physicians, psychiatrists and psychologists. Undergraduate and graduate students are welcomed. The program also covers the great work done by post-doctoral candidates, fellows and world leaders in the field.

Course Description:
The conference aim is to create a critical mass by introducing synergy amongst inter-disciplinary researchers to further understand the brain function and nervous system. It will serve as a platform from which to develop interactions between many of the stakeholders who also have extensive collaborations at national and international levels.

The conference provides the opportunity to be at the forefront of brain sciences, therapeutics in general and neural stem cells interventions in particular. It provides a strong platform for industry and biotech companies to interact with academia in frontiers of science in this field for translational initiatives involving diverse patient's interest groups

Course Topics:
• Neurosurgery (e.g. Image Guided Therapy/intervention, brain tumors and intraoperative navigation,  nanoneurosurgery , stereotactic radiosurgery, minimally invasive therapy, vascular neurosurgery, functional neurosurgery, neurotrauma/military medicine, surgical simulation...)
• Neurology (e.g. Movement Disorders, Neurodegenerative Diseases, Neurooncology, Neuromodulation, epilepsy, autism, brain  and  spinal cord function...)
• Psychiatry (e.g. Opioid, Addiction, medical imaging for psychiatric conditions such as schizophrenia, depression, PTSD...)
• Radiology (e.g. fMRI, PET, Nuclear medicine, MR SPEC, MR-PET, DTI, CT-PET, Focused Ultrasound, SQUID MRI, ultrahigh/low MRI)
• Neuroscience (e.g. stem cell, molecular neuroscience,  image guided  mapping of genes, proteomics, genomics, neurophysiology,...)
• Neuroengineering (e.g. biomaterial & tissue engineering, human brain Machine Interface, brain and spinal cord devices, nanomedicine, extraterrestrial/space medicine & clinical practice, software engineering, electrical and material engineering, aeronautic engineering/space medicine and Radiation Physics/Oncology as well as robotics)
• Nano-Bio-Electronics (e.g. integration of Stem cell/cellular therapy with nanotechnology, medical devices  and  imaging)
• Spinal Cord (e.g. regeneration, stem cell, imaging, implants and biologics  and  imaging...)
• Policy (e.g. healthcare policy issues that affect the treatment delivery, and usage of certain devices/drugs/imaging technologies, FDA regulations and reimbursements, federal and regional regulation impacting healthcare delivery and research funding, Neuroscience-20/G20 Summit Initiative, Brain Technology  and  Innovation Park...) 

Conference Objectives:
• Apply new findings in brain mapping (BM) & therapeutics relevant to their own sub-specialty;
• Describe the effect of the newly developed methods in medical imaging, medical devices, nanotechnology, and stem cell/cellular therapy;
• [When relevant] Design possible future research and developments in BM, therapeutics and nano-bio-electronics;
• Assess possible impacts of new research and development on their own clinical and scientific work;
• Build bridges amongst multiple disciplines;
• Assess cutting-edge technological advancements in BM & therapeutics, such as the emerging field of nano-bio-electronics (integration of nanotechnology with stem cell/cellular therapy, medical imaging and medical devices);
• Recognize advancements in other disciplines and explain how such advancements could help them formulate new diagnostics and treatment modalities; and
• Understand and discuss the roles of governmental agencies, foundations, and industry upon research and development of the field.

Additional details will be posted as soon as they are available.